<?xml version="1.0" encoding="UTF-8"?>
<p id="para40">Ten (28%) patients were asymptomatic latent cases identified because either an adult family member had the infection or they had been exposed to the epidemic area.
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref> Contact tracing was also used to identify paediatric infections during the SARS-CoV and MERS-CoV epidemics.
 <xref rid="bib4" ref-type="bibr">4</xref>, 
 <xref rid="bib5" ref-type="bibr">5</xref> None of the children developed severe illness or died, similar to findings of SARS-CoV paediatric cases in 2002–03.
 <xref rid="bib4" ref-type="bibr">
  <sup>4</sup>
 </xref> The most commonly reported clinical finding in children with COVID-19 was pneumonia (19 [53%]); fever, dry cough, or both were the next most frequent symptoms. All children with COVID-19 were aggressively treated, which was also standard for children with SARS-CoV infection.
 <xref rid="bib4" ref-type="bibr">
  <sup>4</sup>
 </xref> Treatment for COVID-19 consisted of aerosolised interferon alfa in all children, lopinavir–ritonavir syrup twice a day for 14 days in 14 (39%), and supplemental oxygen for six (17%). Paediatric patients were discharged after two negative SARS-CoV-2 PCRs.
</p>
